NuShores Biosciences LLC
NuShores Biosciences LLC, founded in 2014, is dedicated to commercializing patented bone and tissue regeneration technologies developed at the University of Arkansas at Little Rock. The company aims to improve the quality of life for individuals with severe tissue regeneration needs through innovative solutions like the NuCress™ bone scaffold technology, which is designed to promote healing in large segmental bone defects.
NuShores Biosciences LLC
1523 South Bowman St. Suite 3-H, Little Rock, Arkansas 72211
What We Do
A patented technology designed to promote healing of large segmental bone breaks (>2.5 cm) with a focus on cranio-maxillofacial, dental, limbs, and spine applications. The scaffold is unique in its controlled design, shape, and form, and has shelf-life stability and tolerance over a wide range of storage conditions. It is not yet FDA cleared and is not available for sale at this time.
Key People
Funded Projects
NuCress™ Factory in a Box Enables Sterile, On-demand Medical Device Production
This type of portable and automated manufacturing unit could be used in various military settings, from field hospitals to naval medical bays, enabling the on-site production of medical devices.
News & Updates
NuShores Biosciences LLC will receive nearly half a million dollars to be added to their current 3-year contract awarded through the Medical Technology Enterprise Consortium (MTEC).
NuShores Biosciences LLC has been awarded a $50,000 grant from Medical Technology Enterprise Consortium to support the commercialization of their NuCress™ bone filler scaffolds.
Sam Monk, a seasoned medical device professional, will help to lead NuShores’ quality and regulatory efforts for NuCress™ bone regenerative product line.